Your browser is no longer supported. Please, upgrade your browser. Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Novo Nordisk A/S
Index- P/E27.57 EPS (ttm)1.60 Insider Own- Shs Outstand2.12B Perf Week1.10%
Market Cap93.45B Forward P/E22.59 EPS next Y1.95 Insider Trans- Shs Float1.52B Perf Month-0.52%
Income4.26B PEG2.19 EPS next Q- Inst Own9.20% Short Float0.21% Perf Quarter-7.49%
Sales13.84B P/S6.75 EPS this Y20.20% Inst Trans2.18% Short Ratio2.14 Perf Half Y-3.39%
Book/sh2.31 P/B19.10 EPS next Y14.48% ROA39.10% Target Price49.83 Perf Year24.84%
Cash/sh0.51 P/C86.55 EPS next 5Y12.60% ROE68.20% 52W Range35.10 - 49.11 Perf YTD21.64%
Dividend0.61 P/FCF67.46 EPS past 5Y24.90% ROI56.40% 52W High-10.16% Beta0.95
Dividend %1.38% Quick Ratio1.00 Sales past 5Y12.90% Gross Margin83.30% 52W Low25.69% ATR0.67
Employees40700 Current Ratio1.40 Sales Q/Q1.20% Oper. Margin38.10% RSI (14)44.24 Volatility1.45% 1.26%
OptionableYes Debt/Eq0.01 EPS Q/Q7.30% Profit Margin31.00% Rel Volume0.77 Prev Close43.81
ShortableYes LT Debt/Eq0.00 EarningsFeb 02 BMO Payout33.60% Avg Volume1.51M Price44.12
Recom2.00 SMA20-2.00% SMA50-1.07% SMA200-1.98% Volume1,155,415 Change0.71%
May-28-13Upgrade Deutsche Bank Sell → Hold
Mar-31-10Initiated Deutsche Bank Hold
Mar-30-10Downgrade Mehta Partners Outperform → Market Perform
Feb-24-10Upgrade Jefferies & Co Hold → Buy
Jan-15-10Downgrade Jefferies & Co Buy → Hold
Sep-11-09Initiated Jefferies & Co Buy
Aug-07-09Downgrade UBS Buy → Neutral
Aug-07-09Downgrade JP Morgan Overweight → Neutral
May-12-09Initiated Piper Jaffray Buy
Apr-24-09Upgrade Citigroup Hold → Buy
Mar-26-09Upgrade UBS Neutral → Buy
Jan-14-09Downgrade Citigroup Hold → Sell
Oct-06-08Upgrade Deutsche Securities Hold → Buy
Aug-29-08Downgrade Bernstein Mkt Perform → Underperform
Aug-21-08Initiated UBS Neutral
Jun-09-08Upgrade HSBC Securities Underweight → Neutral
Feb-26-08Downgrade Bear Stearns Outperform → Peer Perform
Feb-08-08Upgrade Bernstein Mkt Perform → Outperform
Jan-23-08Upgrade Bear Stearns Peer Perform → Outperform
Aug-09-07Downgrade Lehman Brothers Overweight → Equal-weight
Dec-08-14 04:54PM  How To Profit From The Obesity Epidemic Benzinga
Dec-05-14 05:39PM  Paralegal: Sanofi fired her for whistleblowing AP
Dec-04-14 12:13PM  A Look At 4 ETFs From The 4 'Least Corrupt' Countries Benzinga
Dec-01-14 10:09AM  Australian Diabetes Management Market and Diabetes Diagnostic Devices Market Spurted by $46 Million Between 2005 and 2013 PR Newswire
Nov-26-14 06:55AM  [$$] Novo Could Put Money Where Its Mouth Is at The Wall Street Journal
Nov-24-14 05:15PM  Novo Nordisk's Victoza Recommended for Label Expansion Zacks
07:00AM  Sanofi Shakes Off Patent Losses Morningstar
Nov-20-14 11:44AM  Sanofi's Bullish Pipeline Forecast Underwhelms Street at Investor's Business Daily
Nov-04-14 05:43PM  Media Release - Top 100 Employer CNW Group
Nov-03-14 10:10AM  Novo Nordisk's Earnings Rise in Q3, 2014 Outlook Narrowed Zacks
Oct-31-14 03:07AM  Novo Nordisk A/S (NVO) Shows Strength: Stock Up 6.2% Zacks
Oct-30-14 05:21PM  Market Thorns, Roses, All Time Highs, and ETF All Time Highs... Yahoo Finance Blogs +6.21%
02:35PM  Sanofi Beats on Q3 Earnings but Lantus Outlook Disappoints Zacks
01:10PM  Alcatel-Lucent rallies, Lufthansa slides: Europes big stock movers at MarketWatch
01:02PM  European stocks climb for third straight day at MarketWatch
05:32AM  [$$] Novo Nordisk Reassures Investors at The Wall Street Journal
Oct-29-14 12:51PM  Sanofi Axes CEO, Hit By Multiple Downgrades at Investor's Business Daily
10:16AM  Sanofi fires CEO CNBC
Oct-28-14 08:17PM  Low Drug Sales Drag Down Shares of Sanofi and Gilead at New York Times -5.02%
05:58PM  Market Thorns, Roses, and All Time Highs... Yahoo Finance Blogs
02:42PM  French Drugmaker Sanofi Warns Of Tougher Competition at Investor's Business Daily
12:37PM  Sanofi Diabetes Outlook Signals an 'Undisciplined' Price War may Erupt at The Wall Street Journal
12:29PM  Good gains as European markets close CNBC
09:33AM  Sanofi Stuns Investors as U.S. Price Pressure Bites at The Wall Street Journal
08:39AM  Pharmalot, Pharmalittle: We're Reading About Sanofi, Lilly and Lots More!! at The Wall Street Journal
Oct-25-14 01:26AM  [$$] The Perils of One-Country Funds at
Oct-23-14 03:30PM  Eli Lilly/Boehringer's Diabetes Drug Under FDA Review Zacks
Oct-16-14 07:59AM  Media Advisory - Dare to Tell the Truth About Vaginal Atrophy (VA) PR Newswire
Oct-07-14 06:08PM  Actavis, Jazz, Novo Lead Top World Stocks List at Investor's Business Daily
Oct-01-14 02:39PM  3 Companies Helping To Keep Diabetes Rates Lower Benzinga
Sep-29-14 01:03PM  Today's Stocks Driving Success For The Drugs Industry at TheStreet
Sep-25-14 09:08PM  Interim for Novo Resources Corp. Company Spotlight
Sep-22-14 05:20PM  Novo Nordisk Reveals Fresh Data on Xultophy for Diabetes Zacks
Sep-18-14 06:53PM  Five Leading International Stocks Near Buy Points at Investor's Business Daily
05:24PM  Today's Market Thorns, Roses and All Time Highs... Yahoo Finance Blogs
04:52PM  FDA Approves Lilly's Once-Weekly Shot For Diabetes at Forbes
07:59AM  Novo Nordisk Marks 90 Years of Innovating Diabetes Care PR Newswire
Sep-17-14 05:12PM  The Market's Thorns, Roses, and All Time Highs... Yahoo Finance Blogs
05:10PM  Novo Nordisk's Tresiba Effective in Children & Adolescents Zacks
Sep-12-14 04:10PM  Novo Nordisk's Saxenda Gets Positive Opinion for Obesity Zacks
11:49AM  Aveva sinks; Novo Nordisk climbs: Europes big stock movers at MarketWatch
Sep-11-14 06:08PM  [$$] FDA Panel Recommends Approval of Novo Nordisk Obesity Treatment at The Wall Street Journal
07:59AM  MEDIA ALERT: Denmark's Crown Prince Couple Helps Mark 90 Years of Canadian, Danish Partnership in Innovating Diabetes Care CNW Group
Sep-10-14 09:16PM  New Drug to Treat Obesity Gains Approval by F.D.A. at New York Times
10:41AM  Fat Chance? Novo Hopes to Sell its Injectable Diabetes Med as a Diet Drug at The Wall Street Journal
06:15AM  Investment, Un-American Style at Forbes
Sep-09-14 01:04PM  3 Stocks Boosting The Drugs Industry Higher at TheStreet
Sep-04-14 08:06AM  Piramal, Exelixis And Novo Nordisk Research Woes Spell Doom For Drug Discovery Scientists at Forbes
Sep-03-14 05:20PM  Novo Nordisk Drops Anti-Inflammatory R&D Activities Zacks
03:05PM  [$$] Novo Nordisk's Comeback Needs Nods From Regulators at The Wall Street Journal
Sep-02-14 05:42PM  Booming Biotech Market Benefits REIT BioMed Realty at Investor's Business Daily
02:30PM  [$$] Novo's Comeback Hinges on Regulators at The Wall Street Journal
02:00PM  Novo Nordisk's Ryzodeg Now in Mexico for Type II Diabetes Zacks
Aug-29-14 03:30PM  Eli Lilly-Boehringer Drug's Cost Effectiveness Questioned Zacks
Aug-28-14 01:04PM  NVO, BMRN And ILMN, 3 Health Care Stocks Pushing The Sector Lower at TheStreet
Aug-27-14 06:16PM  [$$] Novo Nordisk CEO Has No Plans for Big Acquisitions at The Wall Street Journal
Aug-26-14 09:33AM  [$$] Novo Nordisk CEO Has No Plans for Big Acquisitions at The Wall Street Journal
Aug-25-14 12:09PM  Deal lifts Roche; Draghi boosts banks: Europes stock moves at MarketWatch
Aug-19-14 04:50PM  Novo Nordisk to Pay Fine, Tresiba in Focus Zacks
Aug-18-14 02:58PM  Novo Nordisk Pays for a Weekend Delay at The Wall Street Journal
Aug-08-14 03:10PM  Novo Nordisk's Earnings Rise on Solid Victoza, Levemir Sales Zacks
Aug-07-14 06:50PM  Salix Q2 Misses Estimates; Novo Nordisk, Mylan Slide at Investor's Business Daily
12:04PM  Novo Nordisk, Mylan Miss Views; Mallinckrodt Beats at Investor's Business Daily
02:29AM  [$$] Novo Nordisk's Net Profit Rises at The Wall Street Journal
Jul-29-14 07:15AM  Novo Nordisk Diabetes Drug Xultophy Gets Positive CHMP View Zacks
Jul-25-14 07:30AM  Novo Nordisk receives positive opinion from CHMP at
07:23AM  EMA recommends approval for Novo Nordisk diabetes treatment at
Jul-17-14 08:49AM  [video] Paying for diabetes pandemic at CNBC
Jul-16-14 01:03PM  3 Stocks Advancing The Drugs Industry at TheStreet
Jul-11-14 05:18PM  Is This MannKind's Greatest Risk? at Motley Fool
Jul-08-14 05:40PM  Sanofi's Basal Insulin Candidate Under FDA Review Zacks
10:30AM  Can Dividend Stocks Novo Nordisk and Novartis Continue to Perform? at Motley Fool
10:30AM  Novo Nordisk Gets FDA Nod for NovoSeven RT Zacks
Jul-07-14 06:18PM  Jazz, Novo Among Medicals Showing Healthy Action at Investor's Business Daily
05:03AM  1 Key Question Remains after MannKind's Giant Leap at Motley Fool
Jul-05-14 05:00PM  3 Things to Look for in MannKind's Partnership at Motley Fool
Jun-30-14 05:00PM  Biogen Hemophilia Drugs Launch Into The Unknown at Investor's Business Daily
04:32PM  MannKind's Afrezza Approved but Will Doctors Prescribe It? at Motley Fool
02:02PM  MannKind Stock: Afrezza Approved at Last, But Will Sales Disappoint? at Motley Fool
11:06AM  Up 9%: What You Need to Know About MannKind Today at Motley Fool
10:38AM  Consider Shire Pharmaceuticals Now; 20%+ Upside Left In Takeover Bid By AbbVie at Seeking Alpha
Jun-27-14 02:22AM  MannKind's Clock Is Ticking, But Balance Sheet Sounds An Alarm at Seeking Alpha
Jun-26-14 06:41PM  Novo, Other Medicals Display Healthy Action at Investor's Business Daily
06:05PM  Novo Nordisk's Diabetes Pill Shows Promise at Seeking Alpha
Jun-24-14 11:00AM  Team Novo Nordisk, the world's first all-diabetes professional cycling team, races in BC Superweek CNW Group
01:11AM  Is Sanofi's Dividend Safe? at Motley Fool
Jun-23-14 04:32PM  Sanofi: Toujeo Is Not The Ace In Its Deck at Seeking Alpha
10:30AM  Novo Nordisk Reveals Positive Data on Victoza 3 mg Zacks
12:01AM  Early Results Arrive on Weight-Loss Pills That Expand in the Stomach at New York Times
Jun-20-14 06:24PM  Who Will Win This $45 Billion Market? at Motley Fool
02:32PM  Health Insurers Pressing Down on Drug Prices at New York Times
11:34AM  The Anti-Obesity Space Is Not As Simple As Some Think at Seeking Alpha
Jun-18-14 04:34PM  Is Novo Nordisk's Dividend Safe? at Motley Fool
03:30PM  A Cost of Doing Business? How Regulatory Fines Hurt Shareholder Returns at The Wall Street Journal
08:46AM  Novo Nordisk (NVO) is in Overbought Territory: What's Next? Zacks
Jun-17-14 03:35PM  Ligand Pharma's LGD-6972 Positive in Phase I Study Zacks
12:34AM  [$$] Novo Nordisk Sees 'No Strategic Reason' For Big Mergers at The Wall Street Journal
Novo Nordisk A/S engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark. It operates in two segments, Diabetes Care and Biopharmaceuticals. The Diabetes Care segment covers insulins, GLP-1 analog, obesity, and oral antidiabetic drugs, as well as other protein related products comprising glucagon, protein related delivery systems, and needles. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth hormone therapy, hormone replacement therapy, and inflammation. The company sells its products primarily in North America, China, Japan, Algeria, Argentina, Australia, Brazil, India, Turkey, and European countries through its subsidiaries, distributors, and independent agents. Novo Nordisk A/S was founded in 1925 and is headquartered in Bagsvaerd, Denmark.